Zentalis Pharmaceuticals Inc (ZNTL)
12.56
+0.04
(+0.32%)
USD |
NASDAQ |
May 10, 16:00
12.56
0.00 (0.00%)
After-Hours: 18:26
Zentalis Pharmaceuticals Total Liabilities (Quarterly): 98.71M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 98.71M |
| December 31, 2023 | 114.30M |
| September 30, 2023 | 103.82M |
| June 30, 2023 | 98.16M |
| March 31, 2023 | 103.68M |
| December 31, 2022 | 105.29M |
| September 30, 2022 | 100.46M |
| June 30, 2022 | 95.03M |
| March 31, 2022 | 90.01M |
| Date | Value |
|---|---|
| December 31, 2021 | 90.02M |
| September 30, 2021 | 41.08M |
| June 30, 2021 | 36.35M |
| March 31, 2021 | 35.72M |
| December 31, 2020 | 32.18M |
| September 30, 2020 | 27.40M |
| June 30, 2020 | 19.29M |
| March 31, 2020 | 176.82M |
| December 31, 2019 | 160.77M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
19.29M
Minimum
Jun 2020
176.82M
Maximum
Mar 2020
84.95M
Average
96.60M
Median
Total Liabilities (Quarterly) Benchmarks
| Revolution Medicines Inc | 235.51M |
| Day One Biopharmaceuticals Inc | 29.84M |
| Perspective Therapeutics Inc | 22.71M |
| Electromed Inc | 6.622M |
| Xtant Medical Holdings Inc | 41.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 557.48M |
| Shareholders Equity (Quarterly) | 458.77M |
| Current Ratio | 9.194 |